Martin J. Connor
Imperial College London
Interquartile rangeCancerInternal medicineRadiologySurgeryMagnetic resonance imagingOncologyRandomized controlled trialPediatricsBiopsyProstate cancer screeningReferralProstateMetastasisProstatectomyMEDLINEProstate cancerProstate biopsyTransperineal Prostate BiopsyMultiparametric Magnetic Resonance ImagingIn patientRadiation therapyImage fusionMedicine
50Publications
11H-index
263Citations
Publications 57
Newest
#1Martin J. ConnorH-Index: 11
#2Mesfin G Genie (Aberd.: University of Aberdeen)H-Index: 4
Last. Tzveta Pokrovska (Imperial College Healthcare)
view all 21 authors...
Introduction null Systemic therapy with androgen deprivation therapy (ADT) and intensification with agents such as docetaxel, abiraterone acetate and enzalutamide has resulted in improved overall survival in men with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC). Novel local cytoreductive treatments and metastasis-directed therapy are now being evaluated. Such interventions may provide added survival benefit or delay the requirement for further systemic agents and asso...
Source
#1A Rai (ICL: Imperial College London)
#2Martin J. Connor (ICL: Imperial College London)H-Index: 11
Last. H Abboudi (ICL: Imperial College London)
view all 12 authors...
Source
#1E. Bass (Imperial College Healthcare)H-Index: 3
#2A PantovicH-Index: 1
Last. Hashim U. Ahmed (Imperial College Healthcare)H-Index: 64
view all 8 authors...
Background null Multiparametric MRI localizes cancer in the prostate, allowing for MRI guided biopsy (MRI-GB) 43 alongside transrectal ultrasound-guided systematic biopsy (TRUS-GB). Three MRI-GB approaches exist; visual estimation (COG-TB); fusion software-assisted (FUS-TB) and MRI 'in-bore' biopsy (IB-TB). It is unknown whether any of these are superior. We conducted a systematic review and meta-analysis to address three questions. First, whether MRI-GB is superior to TRUS-GB at detecting clini...
Source
#1Martin J. ConnorH-Index: 11
#2M. EdisonH-Index: 2
Last. Tim DudderidgeH-Index: 20
view all 13 authors...
Source
#1Martin J. Connor (ICL: Imperial College London)H-Index: 11
#2Suraiya Dubash (ICL: Imperial College London)H-Index: 5
Last. Hashim U. Ahmed (ICL: Imperial College London)H-Index: 64
view all 8 authors...
Abstract Recent evidence from randomised trials supports the diagnostic superiority of prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) over conventional imaging in the detection of distant occult metastasis in men with newly diagnosed high-risk prostate cancer. This may result in a rise in the detection of de novo synchronous hormone-sensitive “oligometastatic” prostate cancer. We outline the evidence supporting PSMA PET/CT imaging in primary...
Source
#1Martin J. ConnorH-Index: 11
Last. Hamid AbboudiH-Index: 13
view all 12 authors...
INTRODUCTION AND OBJECTIVE:Preservation of sexual function whilst alleviating bothersome lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is a major attraction fo...
Source
#7Heminder Sokhi (Hillingdon Hospitals NHS Foundation Trust)H-Index: 4
Introduction Multiparametric magnetic resonance imaging (mpMRI), the use of three multiple imaging sequences, typically T2-weighted, diffusion weighted (DWI) and dynamic contrast enhanced (DCE) images, has a high sensitivity and specificity for detecting significant cancer. Current guidance now recommends its use prior to biopsy. However, the impact of DCE is currently under debate regarding test accuracy. Biparametric MRI (bpMRI), using only T2 and DWI has been proposed as a viable alternative....
Source
Source
#1Martin J. ConnorH-Index: 11
#2Marieke van SonH-Index: 2
Last. E. PegersH-Index: 1
view all 21 authors...
Source
#2Martin J. ConnorH-Index: 11
Last. E. PegersH-Index: 1
view all 21 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.